Heinz Delesen
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria 4
-
- Antibiotic Use and Resistance 2
- Hematology top 10%
- Hemophilia Treatment and Research 4
- Platelet Disorders and Treatments 2
- Pharmacology top 10%
- Antibiotics Pharmacokinetics and Efficacy 9
- Pharmaceutical Science top 10%
-
- Pneumonia and Respiratory Infections 7
-
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 3
-
- Inhalation and Respiratory Drug Delivery 3
- Co-authors
- Heino StaßJohannes NagelschmitzDagmar KubitzaShadan LalezariStefan WillmannAnita ShahSybille BaumannAbhishek Gupta
- Journals
- Haemophilia (3 papers)British Journal of Clinical Pharmacology (2 papers)Clinical Pharmacokinetics (2 papers)
- Partner nations
- GermanyUnited StatesIsrael
In The Last Decade
Heinz Delesen
17 papers receiving 385 citations
Peers
Comparison fields: 5 of 57
- Molecular Medicine 61
- Applied Microbiology and Biotechnology 19
- Hematology 98
- Pharmacology 118
- Pharmaceutical Science 34
Countries citing papers authored by Heinz Delesen
This map shows the geographic impact of Heinz Delesen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heinz Delesen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heinz Delesen more than expected).
Fields of papers citing papers by Heinz Delesen
This network shows the impact of papers produced by Heinz Delesen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heinz Delesen. The network helps show where Heinz Delesen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Heinz Delesen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 1 | |
| 2 | 2018 | 33 | |
| 3 | 2015 | 33 | |
| 4 | 2014 | 40 | |
| 5 | 2013 | 72 | |
| 6 | 2013 | 32 | |
| 7 | 2011 | 10 | |
| 8 | 2011 | 18 | |
| 9 | 2010 | 1 | |
| 10 | 2008 | 20 | |
| 11 | 2008 | 13 | |
| 12 | 2005 | 38 | |
| 13 | 2004 | 10 | |
| 14 | No dose adjustment is needed for patients undergoing hemodialysis receiving oral moxifloxacin | 2002 | 4 |
| 15 | 2002 | 43 | |
| 16 | 2001 | 24 | |
| 17 | 2001 | 14 |
About Heinz Delesen
Heinz Delesen is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine, Pharmacology, Hematology and Genetics, having authored 17 papers that have together received 406 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (9 papers), Pneumonia and Respiratory Infections (7 papers), Antibiotic Resistance in Bacteria (4 papers), Hemophilia Treatment and Research (4 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers), Inhalation and Respiratory Drug Delivery (3 papers), Platelet Disorders and Treatments (2 papers) and Antibiotic Use and Resistance (2 papers). The work is most often cited by research in Molecular Medicine (61 citations), Applied Microbiology and Biotechnology (19 citations), Hematology (98 citations), Pharmacology (118 citations) and Pharmaceutical Science (34 citations). Heinz Delesen has collaborated with scholars based in Germany, United States and Israel. Frequent co-authors include Heino Staß, Johannes Nagelschmitz, Dagmar Kubitza, Shadan Lalezari, Stefan Willmann, Anita Shah, Sybille Baumann, Abhishek Gupta, Doris Staab and Atef Halabi. Their work appears in journals such as Haemophilia, British Journal of Clinical Pharmacology, Clinical Pharmacokinetics, Blood and The Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.